ALK kinase domain mutations in primary anaplastic large cell lymphoma: consequences on NPM-ALK activity and sensitivity to tyrosine kinase inhibitors.
Plos One
Lovisa, Federica F; Cozza, Giorgio G; Cristiani, Andrea A; Cuzzolin, Alberto A; Albiero, Alessandro A; Mussolin, Lara L; Pillon, Marta M; Moro, Stefano S; Basso, Giuseppe G; Rosolen, Angelo A; Bonvini, Paolo P